Purchase Order W91YTZ22P0104
- Not listed
- The Defense Health Agency awarded a $118,080 firm fixed-price purchase order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, for one Cepheid GeneXpert 16x16 diagnostic instrument (Serial Number 842173) and associated computer equipment. The contract, awarded on July 18, 2025, carries an ultimate completion date of August 4, 2025, and involves no set-aside designation. The GeneXpert platform is a widely-utilized point-of-care molecular diagnostic...
- The Defense Health Agency awarded a $225.55K firm fixed-price purchase order to Cepheid Inc. for onsite preventive maintenance, software and hardware updates, and repair and parts replacement services for government-owned Cepheid GeneXpert molecular analyzers. The contract, effective through September 19, 2030, supports diagnostic equipment located in Columbia, South Carolina. This award carries no set-aside designation and reflects the Defense Health Agency's continued reliance on molecular...
- The U.S. Defense Logistics Agency awarded a $6,674.40 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 16, 2025. This delivery order, with a completion date of September 23, 2025, represents a non-set-aside award for diagnostic equipment or testing solutions that will be performed at Cepheid's Sunnyvale facility. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and...
- The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at...
- The Defense Logistics Agency awarded a $6,420 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of October 2, 2025. This delivery order, issued under contract number GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and testing services to the Department of Defense supply chain. Cepheid specializes in advanced...
- The U.S. Department of Defense's Defense Health Agency has awarded a firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for services related to Cepheid's GeneXpert DX Systems in the Department of Pathology. The contract, valued at $326,745.25, has an ultimate completion date of September 10, 2025. Cepheid, the prime contractor, is not designated as a set-aside. The company has a history of providing diagnostic testing equipment,...
- This federal contract award is for the procurement of GeneXpert Infinity 48S molecular diagnostic systems and associated supplies by the Defense Health Agency. The $487,039.20 firm fixed-price purchase order was awarded to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract has an ultimate completion date of January 13, 2027 and does not have a set-aside designation. Cepheid is an original equipment manufacturer and prime...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $199,744.50, is for a standard service agreement for Cepheid's GeneXpert system. The contract has an ultimate completion date of December 10, 2026. Cepheid is the prime contractor and there is no set-aside designation for this award. Cepheid has previously received numerous federal contract and grant awards from agencies...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
The Defense Health Agency awarded a $79,000 firm fixed-price purchase order to Cepheid Inc. for FY 22 GeneXpert analyzers on September 23, 2022, with an ultimate completion date of September 22, 2027. The contract, which carries no set-aside designation, will be performed in Huntsville, Alabama. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The GeneXpert analyzers represent core equipment in Cepheid's product portfolio, which also includes reagents, test kits, and maintenance services designed to detect conditions ranging from COVID-19 and influenza to MRSA and other infections. This purchase order aligns with the Defense Health Agency's broader procurement strategy for diagnostic capabilities across the military healthcare system. Cepheid has an established track record delivering molecular diagnostic solutions to federal healthcare agencies, including the Department of Veterans Affairs and Defense Logistics Agency, through multiple contracts valued up to nearly $1 million. The company holds significant indefinite delivery vehicles with VA networks, including a $32.8 million IDV through Veterans Integrated Service Network 6 for diagnostic reagents and assays through 2030, demonstrating sustained federal demand for Cepheid's diagnostic technologies and the company's competitive positioning in the federal molecular diagnostics market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $13.8k | 8/15/25 | |
| P00004 | Funding Only Action | $13.8k | 7/30/24 | |
| P00003 | Exercise an Option | $0 | 4/19/24 | |
| P00002 | Exercise an Option | $13.8k | 7/26/23 | |
| P00001 | Other Administrative Action | $0 | 9/26/22 |